Skip to content

Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma

Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02691650
Acronym
POCCET
Enrollment
85
Registered
2016-02-25
Start date
2016-02-29
Completion date
2018-10-31
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Trauma

Keywords

serum cholinesterase, plasma cholinesterase, pseudocholinesterase, systemic inflammation, SIRS, polytrauma

Brief summary

Goal of this study is to measure serum cholinesterase activity in patients with traumatic and/or burns injury admitted to the emergency room by using point-of- care-test system (POCT). Serum cholinesterase activity, measured using POCT system, might play an important role in the early diagnosis and prediction of patient outcome in trauma-induced systemic inflammation.

Interventions

None listed

Sponsors

BG Trauma Center Ludwigshafen
CollaboratorOTHER
University Hospital Heidelberg
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* signed written consent * 18 years and older * severe trauma (ISS \> 15) * burns injury (2. degree more than 15% body surface or 3 degree more than 10% body surface) * SIRS

Exclusion criteria

* not fulfilling the inclusion criteria * failure to adhere

Design outcomes

Primary

MeasureTime frameDescription
Early diagnosis of the systemic inflammation by using the serum cholinesterase activity measurementafter completed patient recruitment, 1 yearBy using Point-of-care measurement of serum cholinesterase activity (U/l) and by observing a change in the enzyme activity over time (reduction of serum cholinesterase activity within the first 6 hours after traumatic injury) would allow an additional tool in early diagnosis and treatment of systemic inflammation.

Secondary

MeasureTime frameDescription
correlation of the cholinesterase activity and the trauma/disease severity scoresafter completed patient recruitment, 1 yearTo evaluate the correlation of the serum cholinesterase activity change with the trauma severity, the obtained serum cholinesterase activities (U/l) will be compared to the trauma severity scores (ISS, %TBSA).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026